Biohaven Ltd (BHVN)
48.66
-0.38
(-0.77%)
USD |
NYSE |
Nov 14, 16:00
48.66
0.00 (0.00%)
After-Hours: 18:39
Biohaven Enterprise Value: 4.199B for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 4.199B |
| November 12, 2024 | 4.324B |
| November 11, 2024 | 4.520B |
| November 08, 2024 | 4.618B |
| November 07, 2024 | 4.582B |
| November 06, 2024 | 4.644B |
| November 05, 2024 | 4.423B |
| November 04, 2024 | 4.294B |
| November 01, 2024 | 4.373B |
| October 31, 2024 | 4.267B |
| October 30, 2024 | 4.334B |
| October 29, 2024 | 4.380B |
| October 28, 2024 | 4.456B |
| October 25, 2024 | 4.559B |
| October 24, 2024 | 4.513B |
| October 23, 2024 | 4.550B |
| October 22, 2024 | 4.541B |
| October 21, 2024 | 4.417B |
| October 18, 2024 | 4.570B |
| October 17, 2024 | 4.445B |
| October 16, 2024 | 4.429B |
| October 15, 2024 | 4.357B |
| October 14, 2024 | 4.552B |
| October 11, 2024 | 4.643B |
| October 10, 2024 | 4.427B |
| Date | Value |
|---|---|
| October 09, 2024 | 4.410B |
| October 08, 2024 | 4.626B |
| October 07, 2024 | 4.550B |
| October 04, 2024 | 4.066B |
| October 03, 2024 | 3.973B |
| October 02, 2024 | 4.100B |
| October 01, 2024 | 4.155B |
| September 30, 2024 | 4.287B |
| September 27, 2024 | 4.385B |
| September 26, 2024 | 4.402B |
| September 25, 2024 | 4.217B |
| September 24, 2024 | 3.821B |
| September 23, 2024 | 3.906B |
| September 20, 2024 | 3.382B |
| September 19, 2024 | 3.384B |
| September 18, 2024 | 3.288B |
| September 17, 2024 | 3.250B |
| September 16, 2024 | 3.252B |
| September 13, 2024 | 3.163B |
| September 12, 2024 | 2.943B |
| September 11, 2024 | 2.940B |
| September 10, 2024 | 2.961B |
| September 09, 2024 | 3.003B |
| September 06, 2024 | 3.052B |
| September 05, 2024 | 3.054B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-15.64M
Minimum
Sep 29 2022
4.644B
Maximum
Nov 06 2024
2.069B
Average
1.951B
Median
Oct 20 2023
Enterprise Value Benchmarks
| Scholar Rock Holding Corp | 2.051B |
| Veru Inc | 70.47M |
| Regeneron Pharmaceuticals Inc | 80.57B |
| Vanda Pharmaceuticals Inc | -68.83M |
| Oramed Pharmaceuticals Inc | -58.86M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -319.77M |
| Total Expenses (Quarterly) | 333.77M |
| EPS Diluted (Quarterly) | -3.64 |
| Earnings Yield | -18.93% |